Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials (Q46371451)

21 December 2017

meta-analysis

0 references

editorial

0 references

title

Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials (English)

1 reference

21 December 2017

4

E J Topol

1 reference

21 December 2017

1

S G Ellis

1 reference

21 December 2017

F Van de Werf

2

1 reference

21 December 2017

E Ribeiro-daSilva

series ordinal

3

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 March 1992

1 reference

21 December 2017

Journal of the American College of Cardiology

published in

1 reference

21 December 2017

volume

19

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

681-686

1 reference

21 December 2017

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: A qualitative and quantitative angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

An analysis of time delays preceding thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Discrepancies between the effects of coronary reperfusion on survival and left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Effect of thrombolysis on the evolution of late potentials within 10 days of infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

Prognostic significance of left ventricular ejection fraction after acute myocardial infarction. A bedside radionuclide study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980292-X

7 January 2021

10.1016/S0735-1097(10)80292-X

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

1531664

1 reference

21 December 2017